MGH INSTITUTE FOR TECHNOLOGY ASSESSMENT

The development of NAFLD and NASH is closely linked to obesity, which has reached epidemic proportions in the United States. NAFLD is estimated to be present in up to 30% of the adult population (or 75 million adults) and NASH in around 5% (or 15 million adults) in the United States alone. NASH is now the leading cause in liver transplantation in females in the United States and is expected to become the leading cause in males as well in the near future. In Europe, the prevalence of NAFLD is between 26-33% in the general population and that of NASH is around 5%.

Also known as: MGH

Primary location: Boston United States